Immunocytochemical expression of p16INK4a and HPV l1 capsid proteins as predictive markers of the cervical lesions progression risk

Romanian Journal of Morphology and Embryology

Volumn 51, Issue 3, 2010, Pages 497-503

  Ungureanu, Carmen ^a   Socolov, Demetra ^a   Anton, Gabriela ^b   Mihailovici, Maria Sultana ^a   Teleman, S ^a  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b STEFAN S NICOLAU INSTITUTE OF VIROLOGY   (Romania)

Author keywords

Human papillomavirus (HPV); Immunocytochemistry; L1 capsid protein; Liquid based cytology (LBC); p16INK4a

Indexed keywords

HUMAN PAPILLOMAVIRUS; MIRIDAE;

CAPSID PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; TUMOR MARKER;

ARTICLE; DISEASE COURSE; FEMALE; GENETICS; GENOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PAPILLOMA VIRUS; PATHOLOGY; RISK FACTOR; UTERINE CERVIX TUMOR; VIROLOGY;

CAPSID PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE PROGRESSION; FEMALE; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; PAPILLOMAVIRIDAE; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 77957000252     PISSN: 12200522     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. BOSCH FX, LORINCZ A, MUÑOZ N, MEIJER CJ, SHAH KV, The causal relation between human papillomavirus and cervical cancer, J Clin Pathol, 2002, 55(4):244-265.
2. ZUR HAUSEN H, Papillomaviruses and cancer: from basic studies to clinical application, Nat Rev Cancer, 2002, 2(5):342-350.
3. CANTOR SB, ATKINSON EN, CARDENAS-TURANZAS M, BENEDET JL, FOLLEN M, MACAULAY C., Natural history of cervical intraepithelial neoplasia: a meta-analysis, Acta Cytol, 2005, 49(4):405-415.
4. SCHIFFMAN M, CASTLE PE, JERONIMO J, RODRIGUEZ AC, WACHOLDER S, Human papillomavirus and cervical cancer, Lancet, 2007, 370(9590):890-907.
5. HILFRICH R, HARIRI J, Prognostic relevance of human papillomavirus L1 capsid protein detection within mild and moderate dysplastic lesions of the cervix uteri in combination with p16 biomarker, Anal Quant Cytol Histol, 2008, 30(2):78-82.
6. INK4a and HPV L1 immunohistochemistry is helpful for estimating the behavior of low-grade dysplastic lesions of the cervix uteri, Am J Surg Pathol, 2008, 32(11):1715-1720.
7. SOLOMON D, DAVEY D, KURMAN R, MORIARTY A, O'CONNOR D, PREY M, RAAB S, SHERMAN ME, WILBUR D, WRIGHT TC JR, YOUNG N; FORUM GROUP MEMBERS; BETHESDA 2001 WORKSHOP, The 2001 Bethesda System: terminology for reporting results of cervical cytology, JAMA, 2002, 287(16):2114-2119.
8. RICHART RM, A modified terminology for cervical intraepithelial neoplasia, Obstet Gynecol, 1990, 75(1):131-133.
9. NANDA K, MCCRORY DC, MYERS ER, BASTIAN LA, HASSELBLAD V, HICKEY JD, MATCHAR DB, Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review, Ann Intern Med, 2000, 132(10):810-819.
10. STOLER MH, SCHIFFMANN M; ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE-LOW-GRADE SQUAMOUS INTRAEPITHELIAL LESION TRIAGE STUDY (ALTS) GROUP, Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS- LSIL Triage Study, JAMA, 2001, 285(11):1500-1505.
11. MAYRAND MH, DUARTE-FRANCO E, RODRIGUES I, WALTER SD, HANLEY J, FERENCZY A, RATNAM S, COUTLÉE F, FRANCO EL; CANADIAN CERVICAL CANCER SCREENING TRIAL STUDY GROUP, Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer, N Engl J Med, 2007, 357(16):1579-1588.
12. RONCO G, GIORGI-ROSSI P, CAROZZI F, CONFORTINI M, DALLA PALMA P, DEL MISTRO A, GILLIO-TOS A, MINUCCI D, NALDONI C, RIZZOLO R, SCHINCAGLIA P, VOLANTE R, ZAPPA M, ZORZI M, CUZICK J, SEGNAN N; NEW TECHNOLOGIES FOR CERVICAL CANCER SCREENING WORKING GROUP, Results at recruitment from a randomized controlled trial Comparing human papillomavirus testing alone with conventional cytology as a primary cervical cancer screening test, J Natl Cancer Inst, 2008, 100(7):492-501.
13. BULKMANS NW, BERKHOF J, BULK S, BLEEKER MC, VAN KEMENADE FJ, ROZENDAAL L, SNIJDERS PJ, MEIJER CJ; POBASCAM STUDY GROUP, High-risk HPV type-specific clearance rates in cervical screening, Br J Cancer, 2007, 96(9):1419-1424.
14. SYRJÄNEN K, Mechanisms and predictors of high-risk human papillomavirus (HPV) clearance in the uterine cervix, Eur J Gynaecol Oncol, 2007, 28(5):337-351.
15. NAUCLER P, RYD W, TÖRNBERG S, STRAND A, WADELL G, ELFGREN K, RÅDBERG T, STRANDER B, FORSLUND O, HANSSON BG, HAGMAR B, JOHANSSON B, RYLANDER E, DILLNER J, Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening, J Natl Cancer Inst, 2009, 101(2):88-99.
16. DOORBAR J, The papillomavirus life cycle, J Clin Virol, 2005, 32 Suppl 1: S7-S15.
17. INK4a expression in liquid-based cervical cytology: correlation with HPV testing and histologic diagnosis, Am J Clin Pathol, 2008, 129(4):606-612.
18. INK4a protein in scraped cervical cells, Acta Cytol, 2003, 47(4):616-623.
19. YOSHIDA T, FUKUDA T, SANO T, KANUMA T, OWADA N, NAKAJIMA T, Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials, Cancer, 2004, 102(2):100-108.
20. BOSE S, EVANS H, LANTZY L, SCHARRE K, YOUSSEF E, p16INK4A is a surrogate biomarker for a subset of human papilloma virus-associated dysplasias of the uterine cervix as determined on the Pap smear, Diagn Cytopathol, 2005, 32(1):21-24.
21. INK4a assay: correlation with biopsy follow-up results, Cancer, 2007, 111(2):83-92.
22. INK4a immunostaining in cytolo-gical and histological specimens from the uterine cervix: a systematic review and meta-analysis, Cancer Treat Rev, 2009, 35(3):210-220.
23. MELSHEIMER P, KAUL S, DOBECK S, BASTERT G, Immunocytochemical detection of HPV high-risk type L1 capsid proteins in LSIL and HSIL as compared with detection of HPV L1 DNA, Acta Cytol, 2003, 47(2):124-128.
24. GRIESSER H, SANDER H, WALCZAK C, HILFRICH R, Immunochemical detection of HPV-L1 capsid: a prognostic marker for early squamous lesions of the cervix, Acta Cytologica, 2007, 51(2 Suppl):268.
25. RAUBER D, MEHLHORN G, FASCHING PA, BECKMANN MW, ACKERMANN S, Prognostic significance of the detection of human papilloma virus L1 protein in smears of mild to moderate cervical intraepithelial lesions, Eur J Obstet Gynecol Reprod Biol, 2008, 140(2):258-262.
26. YOSHIDA T, SANO T, KANUMA T, OWADA N, SAKURAI S, FUKUDA T, NAKAJIMA T, Immunochemical analysis of HPV L1 capsid protein and p16 protein in liquid-based cytology samples from uterine cervical lesions, Cancer, 2008, 114(2):83-88.
27. INK4a in cervical lesions, Diagn Cytopathol, 2010, 38(8):573-578.